CBX129801
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for CBX129801, covering 2013-03-01 to 2015-01-30. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Efficacy of CBX129801 in Patients With Type 1 Diabetes [Phase 2]